Close Menu

Somalogic

Investigators from SomaLogic and elsewhere found proteins whose expression levels vary in Duchenne muscular dystrophy, often in conjunction with patients' age.

NEW YORK (GenomeWeb) – In a notice filed on Friday with the US Securities and Exchange Commission, SomaLogic disclosed that it has raised $16.5 million. According to the SEC document, the sale took place on Oct. 17 with equity going to two unidentified investors.

NEW YORK (GenomeWeb) – With new installations and rapidly growing revenues, Somalogic's SOMAscan platform is becoming a significant player in the protein biomarker discovery service space.

NEW YORK (GenomeWeb) – Somalogic said today that Novartis has extended its multi-year research agreement covering the use of Somalogic's aptamer-based proteomics platform for drug development work.

NEW YORK (GenomeWeb) – Children's Hospital Colorado and SomaLogic today announced a collaboration aimed at the discovery of protein biomarkers for diagnosing and managing childhood diseases.

NEW YORK (GenomeWeb) – SomaLogic and NEC today announced an exclusive deal granting NEC exclusive marketing rights to the Somascan assay in Japan.

SomaLogic announced that the Massachusetts General Hospital will this fall begin offering access to the company's Somascan assay.
Based on SomaLogic's somamer affinity reagents, the Somascan platform allows for simultaneous quantification of 1,129 proteins.

NEW YORK (GenomeWeb) – Somalogic said this week that it has joined the Medical Research Council's UK Dementias Research Platform.

Protein Metrics has launched top-down proteomic analysis as part of the 2.0 release of its Byonic proteomics search engine.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

Pages

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.